Prevalence of Parabacteroides distasonis in Aleppo governorate and its antibiotic susceptibility profile

Read full text Summarise with VIRAT
Authors: May Al-Anssari, Zaher Samman Tahan
Cited by: 0
References: 25

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Parabacteroides distasonis is a prominent gut commensal with increasing interest due to its metabolic versatility and potential therapeutic applications. Its abundance is influenced by various host-related factors, including diet, medication, antibiotic exposure, and environmental conditions. This study investigated the prevalence of P. distasonis among residents of Aleppo Governorate and assessed its antibiotic susceptibility patterns. Of the 100 stool samples analyzed, 50 were subjected to culture-based isolation, yielding only two P. distasonis isolates, while the remaining 50 samples (25 from healthy individuals and 25 from patients with type 2 diabetes) were analyzed directly by PCR. The two isolates demonstrated broad multidrug resistance, exhibiting elevated MIC values for ampicillin, clindamycin, amoxicillin-clavulanate, metronidazole, and various cephalosporins. Interestingly, the isolate harboring the rfbA gene showed increased susceptibility to cephalosporins and cefoperazone/sulbactam when compared with the rfbA-negative strain. These findings provide the first regional data on P. distasonis in Syria and emphasize its dual role as both a candidate next-generation probiotic and a potential reservoir of antimicrobial resistance. Ongoing surveillance and molecular characterization are warranted to clarify its therapeutic promise and clinical risks.

Fields of Study & Subjects

Gut microbiota and health Antibiotic Resistance in Bacteria Bacterial Identification and Susceptibility Testing

Publication details

Journal / source
Infection Genetics and Evolution
Volume
140
Pages
105934–105934
Publication date
28 March 2026
Language
EN